HIGH POINT, N.C.--(BUSINESS WIRE)--vTv Therapeutics Inc. (Nasdaq:VTVT), a clinical-stage biopharmaceutical company engaged in the discovery and development of new orally administered treatments for Alzheimer’s disease and diabetes, today announced that Stephen Holcombe, President and CEO and Dr. Larry Altstiel, EVP, Chief Medical Officer, will present a corporate overview at the 18th Annual BIO CEO & Investor Conference on Tuesday, February 9, 2016 at 2:00pm EST. The conference will be held at The Waldorf Astoria in New York City.
